US Patent Litigations are now available. Check here

Explore detailed information on the case number APL_572929/2023 involving Sanofi-Aventis Groupe S.A., Regeneron Pharmaceuticals Inc., Sanofi Winthrop Industrie S.A., and others and Amgen Inc.. Get insights into the proceedings, key dates, and all parties involved. Stay informed with the latest updates from IP Verse.

Case Details

Case Number:APL_572929/2023
Case Filing Date:13 Sep, 2023
Action/Application:Appeal Rop220.2
Decision Number:Ecli:Eu:Up:2023:580110
Decision Date:16 Oct, 2023
Court Division:Appealinstance - Seat - Luxembourg
Language of Proceeding:German
Plaintiffs:

Sanofi-Aventis Groupe S.A.

Regeneron Pharmaceuticals Inc.

Sanofi Winthrop Industrie S.A.

Sanofi-Aventis Deutschland Gmbh

Defendants:

Amgen Inc.

Judges:

Ingeborg Simonsson

Patricia Rombach

Rian Kalden

Case Decision

Decision Date:13 Oct, 2023
Decision Documents:

More cases on Sanofi-Aventis Groupe S.A.

Case Number:CC_586764/2023
Plaintiffs:

Regeneron Pharmaceuticals Inc.

Defendants:

Amgen Inc.

Case Number:ACT_597355/2023
Plaintiffs:

Sanofi Biotechnologies Sas

Regeneron Pharmaceuticals Inc.

Defendants:

Amgen Inc.

Amgen Gmbh

Amgen Europe B.V.

Amgen Nv

Amgen S.R.L.

Amgen B.V.

Amgen S.A.S.

Case Number:ACT_10334/2025
Plaintiffs:

Regeneron Pharmaceuticals Inc.

Sanofi Biotechnology Sas

Defendants:

Amgen S.R.L.

Amgen S.A.S.

Amgen Nv

Amgen Gmbh

Amgen Inc.

Amgen Europe B.V.

Amgen B.V.

More cases on Amgen Inc.

Case Number:CC_586764/2023
Plaintiffs:

Regeneron Pharmaceuticals Inc.

Defendants:

Amgen Inc.

Case Number:ACT_597355/2023
Plaintiffs:

Sanofi Biotechnologies Sas

Regeneron Pharmaceuticals Inc.

Defendants:

Amgen Inc.

Amgen Gmbh

Amgen Europe B.V.

Amgen Nv

Amgen S.R.L.

Amgen B.V.

Amgen S.A.S.

Case Number:ACT_10334/2025
Plaintiffs:

Regeneron Pharmaceuticals Inc.

Sanofi Biotechnology Sas

Defendants:

Amgen S.R.L.

Amgen S.A.S.

Amgen Nv

Amgen Gmbh

Amgen Inc.

Amgen Europe B.V.

Amgen B.V.